Drugs / HavrixTM
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01190215 Comparator | Oct 2010 → Jul 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HavrixTM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01190215 ↗ |
| Modality | Vaccine | “Havrix vaccine” NCT01190215 ↗ |